Finance

Lists
Q3 2026 earnings • released • EPS beat +14 014,11% • Revenue met 0,00%
See results
PHM:BME
Pharma Mar SA
€65,85
-2,44%
(-1,65) 1D
2 Nov., 17:36:00 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHM...
Open
€67,25
High
€67,40
Low
€65,20
Mkt. cap
1,19 mjd
Avg. vol.
27,85 k
Volume
57,28 k
Dividend
1,52%
Quarterly dividend
€0,25
Ex-dividend date
07 Jun. 2023
P/E ratio
20,04
52-wk high
€105,20
52-wk low
€64,00
EPS
€3,29
Shares outstanding
18,00 m
No. of employees
505
Open
€67,25
High
€67,40
Low
€65,20
Mkt. cap
1,19 mjd
Avg. vol.
27,85 k
Volume
57,28 k
Dividend
1,52%
Quarterly dividend
€0,25
Ex-dividend date
07 Jun. 2023
P/E ratio
20,04
52-wk high
€105,20
52-wk low
€64,00
EPS
€3,29
Shares outstanding
18,00 m
No. of employees
505
News stories
From web sources and news partners
About Pharma Mar SA
CEO-
Employees505
Founded1986
Headquarters-
Sector-
Last report
29 Okt. 2026
Fiscal period
Q3 2026
€0,47 / €0,00
+14 014,11%beat
Revenue / Est. (EUR)
0,00 / 50,68 m
0,00%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
90,48 m
42,90 m
49,60 m
54,42 m
Cost of goods sold
3,77 m
3,66 m
4,73 m
3,67 m
Cost of revenue
3,77 m
3,66 m
4,73 m
3,67 m
Research and development expenses
25,59 m
20,88 m
26,38 m
24,86 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,31 m
15,31 m
17,12 m
15,53 m
Operating expense
43,09 m
38,62 m
46,28 m
43,10 m
Total operating expenses
46,87 m
42,28 m
51,01 m
46,77 m
Operating income
43,61 m
622,00 k
-1,40 m
7,65 m
Other non operating income
-
-
-
-
EBT including unusual items
44,28 m
1,60 m
-993,00 k
8,14 m
EBT excluding unusual items
44,28 m
1,60 m
-993,00 k
8,14 m
Income tax expense
-15,39 m
65,00 k
-21,00 k
-1,00 k
Effective tax rate
-34,75%
4,07%
2,11%
-0,01%
Other operating expenses
195,00 k
2,43 m
2,77 m
-
Net income
59,66 m
1,53 m
-972,00 k
8,14 m
Net profit margin
65,95%
3,57%
-1,96%
14,96%
Earnings per share
-
-
-
-
Interest and investment income
3,44 m
976,00 k
412,00 k
492,00 k
Interest expense
-724,00 k
-
-
-
Net interest expenses
2,72 m
976,00 k
412,00 k
492,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
45,64 m
2,71 m
700,00 k
9,78 m
Gain or loss from assets sale
-754,00 k
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme